Zielbio

Developer of targeted therapeutics for cancer

placeCharlottesville, Virginia, United States calendar_todayFounded 2010 groups10 employees language zielbio.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 248 times.

YearFilings
20211
20221
20232
20242
20251

Investor mix

6 investors on record; lead investors include Center for Innovative Technology, 5Y Capital, Partners Health Care Innovation, Morningside.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%
Coming soon